Fact sheet from the WHO on bacterial resistance.
Links of interest
React Network
“ReAct - Action on Antibiotic Resistance” links a wide range of individuals, organizations and networks around the world taking concerted action to respond to antibiotic resistance. ReAct believes that antibiotics should be used appropriately, their use reduced when of no benefit and their correct and specific use increased when needed, and that hospital and community infectious diseases should be prevented through improved infection control and better hygiene and nutrition.
The ROAR project
The Reservoirs of Antibiotic Resistance (ROAR) project, coordinated by the Alliance for the Prudent Use of Antibiotics and currently funded by a 5-year grant from the National Institute of Allergy and Infectious Diseases, is an unprecedented effort to improve scientific understanding of the role of commensal bacteria in the spread of antimicrobial resistance.
The European Antimicrobial Resistance Surveillance System
The EARSS is a European wide network of national surveillance systems, providing reference data on antimicrobial resistance for public health purposes. This network receives funding from the European Commission’s Directorate-General for Health and Consumer Affairs (DG SANCO).
The European Surveillance of Antimicrobial Consumption
The European Surveillance of Antimicrobial Consumption (ESAC) project is funded by the European Centre for Disease Prevention and Control (ECDC) to continue surveillance of antimicrobial agents in Europe for another three years (September 2007 – August 2010; Grant Agreement 2007/001).
IDSA
The Infectious Diseases Society of America (IDSA) represents physicians, scientists and other health care professionals who specialize in infectious diseases. IDSA’s purpose is to improve the health of individuals, communities, and society by promoting excellence in patient care, education, research, public health, and prevention relating to infectious diseases.
NARMS
The National Antimicrobial Resistance Monitoring System (NARMS) was established in 1996 as a collaborative effort between the Food and Drug Administration's Center for Veterinary Medicine, U.S. Department of Agriculture, and the Centers for Disease Control and Prevention. The NARMS program monitors in the USA changes in antimicrobial drug susceptibilities of selected enteric bacterial organisms in humans, animals, and retail meats to a panel of antimicrobial drugs important in human and animal medicine.
